rituximab popular tagged News at allvoices.com

rituximab news

News tagged with “rituximab”. Found: 106 tagged news reports.
 

Your Search Returned 106 tagged news reports

 
Related Tags:

San Diego :: CA :: USA | 1 month ago

Credibility Credibility of 5

For a young biotech company looking to woo investors, it helps to have promising products...Receptos, a developer of drugs for autoimmune disorders such as multiple sclerosis, has both. That combination helps explain why shares of the La Jolla

Tags:

Rome :: Italy | 3 months ago

Credibility Credibility of 5

Most patients taking rituximab could forego standard (and toxic) immunosuppressive medications. Just one dose of rituximab could provide these benefits for at least one year. Idiopathic nephrotic syndrome has an estimated incidence of 1.5 to 2 per

Tags:

Brussels :: Belgium | 3 months ago

Credibility Credibility of 5

European Commission approve Roche's MabThera (rituximab) 1400mg solution for subcutaneous (SC) injection for the treatment of patients with common forms of non-Hodgkin lymphoma (NHL). At present, the drug is delivered by an intravenous infusion which

Tags:

New York City :: NY :: USA | 3 months ago

Credibility Credibility of 5

This study demonstrates that we may no longer need to use chemotherapy in CLL," said Richard R. Furman, director of CLL Research at Weill Cornell Medical College in New York City. "Even if this cancer remains incurable, it now can be treated as if it

Tags:

Charlottesville :: VA :: USA | 3 months ago

Credibility Credibility of 5

Slow-growing, or indolent, non-Hodgkin lymphomas are difficult to treat, with most patients relapsing repeatedly and the disease becoming increasingly resistant to therapy over time. But a new drug made by Seattle-based Gilead Sciences Inc. appears

Tags:

Rishon Le Zion :: Israel | 5 months ago

Credibility Credibility of 5

US Food and Drug Administration (FDA) has granted orphan drug exclusivity for Treanda through October 2015 for the treatment of indolent B-cell non-Hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a

Tags:

London :: United Kingdom | 5 months ago

Credibility Credibility of 5

These grants were made possible through a grant from Onyx Pharmaceuticals, an Amgen subsidiary, to scientifically evaluate and define clinical effectiveness of carfilzomib and oprozomib in non-Hodgkin lymphomas. ORP is to improve cancer care by

Tags:

London :: United Kingdom | 5 months ago

Credibility Credibility of 5

Topics The logo of Swiss pharmaceutical company Roche is seen at a plant in the central Swiss village of Rotkreuz November 6, 2013. Roche's newly approved leukemia drug Gazyva helped patients live nearly a year longer without the disease worsening

Tags:

London :: United Kingdom | 6 months ago

Credibility Credibility of 5

Gazyva is a new monoclonal antibody designed to attach to CD20, a protein found only on B-cells, and it works by helping certain immune system cells to attack cancer cells. The drug is claimed to be the first to receive the FDA's breakthrough therapy

Tags:

Geneva :: Switzerland | 6 months ago

Credibility Credibility of 5

Swiss drugmaker Roche Holding AG has reported a 6 percent increase in overall sales for the first nine months of 2012, based on demand for its cancer drugs. The Basel, Switzerland-based company says its group sales over three quarters rose to 34.9

Tags:



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.